Please provide your email address to receive an email when new articles are posted on . The CDC, IDSA and other agencies created updated guidance for treating drug-susceptible and drug-resistant TB.

The goals for treatment of tuberculosis are to cure the individual patient and to minimize the transmission of Mycobacterium tuberculosis. It is the responsibility of the prescribing physician to ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, ...

Please provide your email address to receive an email when new articles are posted on . Pregnant women treated with regimens including bedaquiline and/or delamanid had positive treatment outcomes.

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

🛍️ Prime Big Deal Days: 50+ actually good deals 🛍️ By Laura Baisas Published Jan 29, 2025 5:00 PM EST Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in ...

Tuberculosis (TB) may last for several months, with treatment. The length of time it takes to cure the condition can vary. It may depend on whether the TB is latent or active. Tuberculosis (TB) is a ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...